as 12-18-2024 1:39pm EST
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.
Upcoming Earnings Alert:
Get ready for potential market movements as Moolec Science SA MLEC prepares to release earnings report on 24 Dec 2024.
Founded: | 2008 | Country: | Luxembourg |
Employees: | N/A | City: | N/A |
Market Cap: | 33.0M | IPO Year: | N/A |
Target Price: | $6.00 | AVG Volume (30 days): | 21.3K |
Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.19 | EPS Growth: | N/A |
52 Week Low/High: | $0.75 - $3.25 | Next Earning Date: | 12-24-2024 |
Revenue: | $5,625,124 | Revenue Growth: | 521.53% |
Revenue Growth (this year): | 20.42% | Revenue Growth (next year): | 30.00% |
MLEC Breaking Stock News: Dive into MLEC Ticker-Specific Updates for Smart Investing
Bloomberg
2 months ago
ACCESSWIRE
2 months ago
Simply Wall St.
2 months ago
ACCESSWIRE
3 months ago
GuruFocus.com
3 months ago
ACCESSWIRE
3 months ago
ACCESSWIRE
3 months ago
ACCESSWIRE
3 months ago
The information presented on this page, "MLEC Moolec Science SA - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.